Symptom prevalence and functional status among patients with advanced head and neck cancer: The observational study

Symptom prevalence and functional status among patients with advanced head and neck cancer: The observational study - Symptom prevalence with advanced head and neck cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004728

Enrollment

Registered

2011-01-01

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Written informed consent 2. age > 19 y.o. 3. The patients diagnosed stage 4 head and neck carcinoma evaluated as incurable. 1) oral cancer 2) nasal cavity and paranasal cancer 3) nasopharyngeal cancer 4) oropharyngeal cancer 5) hypopharyngeal cancer 6) laryngeal cancer 7) thyroid cancer 8) salivary gland cancer 4. hospitalized patient 5. Exclude surgical, radiological or oncological treatments with the primary intent of tumor reduction in the 2 weeks prior to study. 6. clear consciousness 7. PS (ECOG) 3-4

Exclusion criteria

Exclusion criteria: 1. renal failure (Cr>2.0mg/dL), heart failure (NYHA 2-4), liver failure (Total bil>2mg/dL) 2. liver cirrhosis, nephrotic syndrome, protein-losing syndrome

Design outcomes

Primary

Measure	Time frame
Evaluate overall QOL of advanced head and neck cancer with EORTC-QLQ-C15-PAL	—

Secondary

Measure	Time frame
Evaluate subscale of EORTC QLQ-C15-PAL, amount of airway secretions, Typical symptoms of head and neck cancer	—

Countries

Japan

Contacts

Public ContactTakeshi Shinozaki

National Cancer Center Hospital East Division of Head and Neck Surgery

tashinoz@east.ncc.go.jp04-7133-1111

Outcome results